Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function?

European Journal of Surgical Oncology

Volumn 23, Issue 3, 1997, Pages 224-227

  Reynolds, J L ^a   Akhter, J ^a   Adams, W J ^a   Morris, D L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cimetidine; Colon cancer; Histamine content; Lymphocytes

Indexed keywords

CIMETIDINE; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST;

ARTICLE; CANCER GROWTH; CLINICAL TRIAL; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN TISSUE; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; RADIOENZYMATIC ASSAY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; TISSUE LEVEL;

EID: 0030846364     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)92388-X     Document Type: Article

References (26)

1. Adams WJ, Lawson JA, Morris DL. Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Cut 1994; 35: 1632-6.
2. Bartholeyns J, Bouclier M. Involvement of histamine in growth of mouse and rat tumours: antitumoural properties of monofluoromethylhistidine. an enzyme activated irreversible inhibitor of histidine decarboxylase. Cancer Res 1984; 44: 639-45.
3. Woolley DE, Eckley D, Tellow LC, Whitehead RJ. Effect of mast cell products and histamine on the proliferative behaviour of human melanoma and carcinoma cells in vitro. Agents Actions 1993: 38 (special conference issue): C182-C184.
4. Garcia-Caballero M, Nunez de Castro I, Kusche J, Vara-Thorbeck C. Histamine metabolism in human breast and colorectal cancer. Its effects on other host tissue. In: Garcia-Caballero M, Brandes LJ. Hosoda S (eds) Histamine in Normal and Cancer Cell Proliferation. Oxford: Peregmon Press. 1993: 273-88.
5. Ogden BE, Hill HR, Histamine regulates lymphocyte mitogenic response through activation of specific H1 and H2 histamine receptors. Immunology 1980; 41: 107-14.
6. 1 antagonists reduce their proliferative and cytotoxicity. Cell Immunol 1994; 156: 212-9.
7. Berman JS, McFadden RG, Cruikshank WW, Center DM, Beer DJ, Functional characteristics of histamine receptor bearing mononuclear cells. J Immunol 1984; 133: 1495-504.
8. Berman JS, Cruikshank WW, Center, DM, Theodore AC, Beer DJ, Chemoattractant lymphokines specific for the helper/inducer T-Lymphocyte subset. Cell Immunol 1985; 95: 105-12.
9. Adams WJ, Morris DL, Short-course cimetidine and survival with colorectal cancer. Lancet 1994; 344: 1768-9.
10. Svendsen LB, Ross C, Knigge U, et al. Cimetidine as an adjuvant treatment in colorectal cancer. A double-blind, randomized pilot study. Dis Colon Rectum 1995: 38: 514-8.
11. Matsumoto S. Cimetidine and survival with colorectal cancer. Lancet 1995: 346: 115.
12. Morris DL, Adams WJ, Cimetidine and colorectal cancer - old drug, new use? Nature Med 1995: 1: 1243-4.
13. Tonnesen H, Knigge U, Bulow S, et al. Effect of cimetidine on survival after gastric cancer. Lancet 1988; 2: 990-2.
14. Jass J. A new prognostic classification of rectal cancer. Lancet 1987: 1: 1303-6.
15. Henry DP, Bowsher RR, Verburg VM. Radioenzymatic assay for histamine: development and validation. Scand J Gastroenterol 1991; 26 (Suppl. 180): 26-31.
16. Chanda R, Ganguly AK. Diamineoxidase activity and tissue histamine content of human skin, breast and rectal carcinoma. Cancer Lett 1998; 34: 207-12.
17. Garcia-Caballero M, Neugebauer E, Rodriguez F, Nunez de Castrol, Vara-Thorbeck C. Histamine synthesis and content in benign and malignant breast tumours. Its effects on other host tissues. Surg Oncol 1994; 3: 167-73.
18. Burtin C, Scheinmann P, Salomon JC, et al. Increased tissue histamine in tumour bearing mice and rats. Br J Cancer 1981: 43: 684-8.
19. Zwadlo-Klarwasser G, Braam U, Muhlzurbes P. Schmutzler W. Macrophages and lymphocytes: alternative sources of histamine. Agents Actions 1994: 41 (special conference issue): C99-C100.
20. Oh C, Suzuki S, Nakashima I, Yamashita K, Nakano K, Histamine synthesis in non-mast cells through mitogen dependent induction of histidine decarboxylase. Immunology 1988; 65: 143-8.
21. Galoppin L, Noirot C, Wastiaux JP, Scheinmann P, Paupe J, Burtin C. Comparison between number of basophils, blood histamine and histamine release in cancer and non cancer patients. J Allergy Clin Immunol 1989; 84: 501-6.
22. 1 receptor agonists, respectively. Immunology 1982; 79: 5052-6.
23. Khan MM, Keaney KM, Melmon KL, Clayberger C, Krensky AM, Histamine regulates the generation of human cytolytic T lymphocytes. Cell Immunol 1989; 121: 60-73.
24. Fisher ER, Paik SM, Rockette H, Jones J, Caplan R, Fisher B. Prognostic significance of eosinophils and mast cells in rectal cancer. Hum Pathol 1989; 20: 159-63.
25. Jeziorska M, Haboubi NY, Schofield PF, Woolley DE, Mast cell distribution and tumour cell proliferation in colonic carcinoma. Gut 1993; 34 (Suppl. 1): S5.
26. Kh Dabbous M, Haney L, Nicolson GL, Eckley D, Woolley DE. Mast cell modulation of tumour cell proliferation in rat mammary adenocarcinoma 13762NF. Br J Cancer 1991; 63: 873-8.